90733 Mpsv4 vaccine subcutaneous
Medicine
Also known as: Menomune, MPSV4, Meningococcal MPSV4
Meningococcal vaccine, polysaccharide, 4-valent (MPSV4) administered subcutaneously for prevention of meningococcal disease caused by serogroups A, C, W-135, and Y.
Clinical Context
Administered to individuals 55 years and older, military recruits, and those at high risk for meningococcal disease for prevention of meningococcemia and meningitis.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.